We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Power analysis for idiographic (within-subject) clinical trials: Implications for treatments of rare conditions and precision medicine.
- Authors
Tueller, Stephen; Ramirez, Derek; Cance, Jessica D.; Ye, Ai; Wheeler, Anne C.; Fan, Zheng; Hornik, Christoph; Ridenour, Ty A.
- Abstract
Power analysis informs a priori planning of behavioral and medical research, including for randomized clinical trials that are nomothetic (i.e., studies designed to infer results to the general population based on interindividual variabilities). Far fewer investigations and resources are available for power analysis of clinical trials that follow an idiographic approach, which emphasizes intraindividual variabilities between baseline (control) phase versus one or more treatment phases. We tested the impact on statistical power to detect treatment outcomes of four idiographic trial design factors that are under researchers' control, assuming a multiple baseline design: sample size, number of observations per participant, proportion of observations in the baseline phase, and competing statistical models (i.e., hierarchical modeling versus piecewise regression). We also tested the impact of four factors that are largely outside of researchers' control: population size, proportion of intraindividual variability due to residual error, treatment effect size, and form of outcomes during the treatment phase (phase jump versus gradual change). Monte Carlo simulations using all combinations of the factors were sampled with replacement from finite populations of 200, 1750, and 3500 participants. Analyses characterized the unique relative impact of each factor individually and all two-factor combinations, holding all others constant. Each factor impacted power, with the greatest impact being from larger treatment effect sizes, followed respectively by more observations per participant, larger samples, less residual variance, and the unexpected improvement in power associated with assigning closer to 50% of observations to the baseline phase. This study's techniques and R package better enable a priori rigorous design of idiographic clinical trials for rare diseases, precision medicine, and other small-sample studies.
- Subjects
INDIVIDUALIZED medicine; CLINICAL trials; MONTE Carlo method; MEDICAL research; STATISTICAL power analysis; SOCIAL innovation
- Publication
Behavior Research Methods, 2023, Vol 55, Issue 8, p4175
- ISSN
1554-351X
- Publication type
Article
- DOI
10.3758/s13428-022-02012-1